Dimitrios Mavroudis Selected Research

Dimitrios Mavroudis Research Topics

Disease

39	Neoplasms (Cancer) 01/2024 - 09/2002
36	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2003
12	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2022 - 04/2015
7	Circulating Neoplastic Cells 07/2021 - 01/2015
6	Disease Progression 08/2022 - 06/2003
4	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2005
3	Melanoma (Melanoma, Malignant) 12/2023 - 01/2015
3	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 04/2020
3	Neutropenia 12/2014 - 08/2003
3	Fever (Fevers) 08/2014 - 08/2003
2	Febrile Neutropenia 10/2023 - 08/2003
2	Triple Negative Breast Neoplasms 01/2023 - 01/2019
2	Heart Failure 04/2016 - 11/2007
2	Thrombocytopenia (Thrombopenia) 12/2014 - 08/2003
1	Liposarcoma 11/2023
1	Heart Diseases (Heart Disease) 06/2023
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 04/2022
1	Cachexia 08/2021
1	Weight Loss (Weight Reduction) 08/2021
1	Autoimmune Diseases (Autoimmune Disease) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Superior Vena Cava Syndrome (Superior Vena Cava Obstruction) 12/2020
1	Colonic Neoplasms (Colon Cancer) 07/2020
1	Ovarian Epithelial Carcinoma 04/2020
1	Microsatellite Instability 04/2020
1	Turcot syndrome 04/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2020
1	Hypoxia (Hypoxemia) 01/2020

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 06/2023 - 11/2007
9	MicroRNAs (MicroRNA)IBA 01/2024 - 11/2018
9	Proteins (Proteins, Gene)FDA Link 06/2023 - 02/2013
7	Estrogen ReceptorsIBA 03/2022 - 12/2017
5	Immune Checkpoint InhibitorsIBA 12/2022 - 04/2020
5	PlatinumIBA 01/2021 - 08/2014
5	Docetaxel (Taxotere)FDA Link 07/2017 - 09/2002
4	Tyrosine Kinase InhibitorsIBA 09/2022 - 07/2005
4	Paclitaxel (Taxol)FDA LinkGeneric 12/2014 - 09/2002
3	Hormones (Hormone)IBA 01/2023 - 01/2021
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2021 - 01/2005
3	DNA (Deoxyribonucleic Acid)IBA 07/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 07/2020 - 04/2015
3	Gemcitabine FDA Link 02/2020 - 09/2002
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 02/2013
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2016
3	Epirubicin (Ellence)FDA LinkGeneric 07/2017 - 11/2007
2	Everolimus FDA Link 01/2023 - 04/2022
2	B7-H1 AntigenIBA 01/2023 - 08/2021
2	Progesterone Receptors (Progesterone Receptor)IBA 03/2022 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 06/2021 - 07/2005
2	ElementsIBA 01/2021 - 02/2013
2	Carboplatin (JM8)FDA LinkGeneric 10/2019 - 07/2005
2	AnthracyclinesIBA 07/2017 - 12/2014
2	Taxoids (Taxanes)IBA 07/2017 - 08/2012
2	Fluorouracil (Carac)FDA LinkGeneric 12/2014 - 01/2005
2	Trastuzumab (Herceptin)FDA Link 12/2011 - 06/2003
1	ParaffinIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	NivolumabIBA 01/2023
1	Axitinib (AG 013736)IBA 01/2023
1	cabozantinibIBA 01/2023
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 01/2023
1	methyl 4-azidophenylacetimidate (APAI)IBA 09/2022
1	osimertinibIBA 09/2022
1	eribulin FDA Link 08/2022
1	ORALIT (ORS)IBA 03/2022
1	Programmed Cell Death 1 ReceptorIBA 08/2021
1	16S Ribosomal RNAIBA 07/2021
1	Circulating Tumor DNAIBA 07/2021
1	Proton Pump InhibitorsIBA 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	AlbuminsIBA 01/2021
1	SteroidsIBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	nitinolIBA 12/2020
1	Cell-Free Nucleic AcidsIBA 11/2020
1	Pyruvate KinaseIBA 07/2020
1	Protein Isoforms (Isoforms)IBA 07/2020
1	AntioxidantsIBA 04/2020
1	CTLA-4 AntigenIBA 04/2020
1	Antineoplastic Agents (Antineoplastics)IBA 04/2020
1	Tamoxifen FDA LinkGeneric 01/2020
1	delta proteinIBA 01/2020
1	LigandsIBA 01/2020
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2020
1	Homeodomain Proteins (Proteins, Homeobox)IBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 10/2019

Therapy/Procedure

17	Drug Therapy (Chemotherapy) 10/2023 - 09/2002
15	Therapeutics 12/2023 - 10/2007
8	Immunotherapy 10/2023 - 01/2015
7	Adjuvant Chemotherapy 09/2023 - 07/2005
6	Radiotherapy 11/2023 - 08/2003
1	Molecular Targeted Therapy 01/2023
1	Aftercare (After-Treatment) 08/2022
1	Craniotomy 11/2021
1	Operative Surgical Procedures 08/2021
1	Duration of Therapy 07/2021
1	Stents 12/2020